Viewing nowOsteron Tablet 150 mg (Risedronate Sodium 2.5 Hydrate)
Risedronate Sodium 2.5 Hydrate 172.1mg
Tablet · Prescription medication
Hwa Il Pharmaceutical Co., Ltd.

MFDS item code 201003163 · Approved 2010.04.29
Treatment and prevention of osteoporosis in postmenopausal women
This medication is used to treat and prevent osteoporosis that may occur in postmenopausal women. Osteoporosis is a condition where bones weaken, leading to an increased risk of fractures. This medication helps maintain bone strength and reduce the risk of fractures.
1. Adults : Administer 150 mg of risedronate sodium orally once monthly. 2. Older adults : No dosage adjustment is necessary in older adults (over 60 years) because the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or more. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30 mL/min. ○ Food interferes with the absorption of this medicine. For adequate absorption, take it at least 30 minutes before the first food or beverage other than water of the day. To help this medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this medicine on the scheduled dosing day, follow these instructions. - If the next scheduled dosing day is 7 days or more away, take 1 tablet the morning after remembering. Resume taking the next dose on the originally scheduled dosing day. Do not take more than 1 tablet of this medicine within 7 days. - If the next scheduled dosing day is within 7 days, wait until the originally scheduled dosing day and then take 1 tablet of this medicine.
The safety and efficacy of this medicine in children under 18 years of age have not been established.
This medication can irritate the gastrointestinal mucosa, so special caution should be exercised in patients with esophageal or gastric issues. Patients with esophageal strictures or achalasia, hypocalcemia, severe renal impairment, pregnant or breastfeeding women should not take this medication. It should be taken with a sufficient amount of water, and you should not lie down for at least 30 minutes after taking it. This medication can cause serious esophageal adverse reactions such as esophagitis, esophageal ulcers, or esophageal obstruction, so if symptoms occur, you should stop taking it immediately and consult a physician. Additionally, it is important to intake sufficient calcium and vitamin D, and if there are existing hypocalcemia or other bone metabolism disorders, treatment should be received first. Rarely, serious side effects such as osteonecrosis of the jaw or atypical fractures may occur with prolonged use, so if any unusual symptoms arise, consult a specialist. This medication may interact with other drugs, so be careful not to take it with drugs or food that contain calcium, magnesium, or iron. If pregnant or breastfeeding, avoid taking this medication or consult a specialist. The safety and efficacy of this medication have not been established for children or adolescents under 18 years old. In case of overdose, blood calcium and phosphorus levels may decrease, and immediate treatment should be sought if symptoms appear. This medication should be kept out of reach of children and should not be stored in a container different from the original.
Esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, upper gastrointestinal mucosal irritation, gastric ulcer, duodenal ulcer, dyspepsia, diarrhea, abdominal pain, nausea, vomiting, constipation, allergic reactions, hypertension, peripheral edema, arthralgia, arthritis, bone trauma, joint abnormalities, myalgia, bone pain, dizziness, depression, insomnia, bronchitis, sinusitis, rhinitis, pharyngitis, increased cough, rash, cataract, urinary tract infection, mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, angioedema, blisters, jaw necrosis, iris inflammation, uveitis, scleritis, liver dysfunction, jaundice, anorexia, asthenia, heartburn, epigastric pain, chest discomfort, palpitations, increased sweating, facial flushing, burning sensation, kidney stones, belching, hematuria, fever, ocular pain, acute phase response, febrile response, influenza-like symptoms, external auditory canal osteonecrosis, atypical fractures, hypocalcemia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering. It is recommended to keep it at room temperature between 1 and 30 degrees Celsius. Doing so will help maintain the medication’s effectiveness and prevent deterioration.
Bright blue oval film-coated tablets
1 tablet
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRisedronate Sodium 2.5 Hydrate 172.1mg
Tablet · Prescription medication
Hwa Il Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

Risedronate Sodium 2.5 Hydrate 35mg
Tablet · Prescription medication
Hyutecs Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.2mg
Tablet · Prescription medication
Celix Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.